BioSpace News Archive

THREAD, a technology and service provider enabling decentralized clinical trials (“DCTs”), today announced the launch of a new offering, THREAD DESIGN.

New data from the ongoing TARGET-IBD study found older patients (>65 years) are significantly more likely to receive aminosalicylate monotherapy as a treatment for both Crohn’s disease and ulcerative colitis compared to their younger counterparts.

Aeglea BioTherapeutics, Inc. today announced the appointment of Marcio Souza to its board of directors.

Dr. Kefas Mugittu (Ph.D.) and Mr. Christopher Ramirez have officially been appointed as co-chief executive officers of Houston -based biotechnology company Stramsen Biotech Inc.

Imanis Life Sciences announced the publication of a peer-reviewed scientific paper detailing its latest improved IMMUNO-COVTM neutralization assay in mSphere®, an open access journal published by the American Society for Microbiology.

Ormco Corporation today announced its introduction of a revolutionary passive self-ligation braces technology with the launch of its new Damon Ultima ™

Glytec today announced the appointment of Nausheen Moulana as Chief Technology Officer.

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions announced today that it has entered into exclusive negotiations with respect to a potential acquisition of all outstanding shares of Voluntis (ENXTPA: ALVTX), a pioneer in digital therapeutics.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced its inaugural event, NeXT Level Biomarkers Symposium , which will showcase novel research into emerging biomarkers using the Personalis NeXT Platform ™.

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced that the European Commission has purchased an additional 150 million doses of Moderna’s COVID-19 vaccine, including the ability to purchase other COVID-19 vaccine candidates from Moderna’s pipeline.